INCY Incyte PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: INCY
- PE Ratio
As of Jul 3, 2025, the Incyte stock's PE ratio is 236.03. This results from the current EPS of $0.29 and stock price of $68.45. The P/E ratio has decreased by 21% from the past four quarters average of 297.2.
INCY PE ratio history
The PE ratio of Incyte has averaged 200.05 over the last ten years. The current PE ratio of 236.03 is 18% above the historical average. In the past ten years, INCY's PE ratio was at its highest in the Dec 2015 quarter at 2,711.25, when the stock price was $108.45 and the EPS was $0.04. The lowest value was in the Sep 2022 quarter, when it reached 16.83 with a price of $66.64 and an EPS of $3.96.
Incyte PE ratio by year
Maximum annual increase: 1,735.42% in 2024
Maximum annual decrease: -93.28% in 2016
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 431.69 | 1,735.42% | $69.07 | $0.16 |
| 2023 | 23.52 | -55.2% | $62.79 | $2.67 |
| 2022 | 52.5 | 207.56% | $80.32 | $1.53 |
| 2021 | 17.07 | N/A | $73.4 | $4.3 |
| 2020 | N/A | N/A | $86.98 | -$1.36 |
| 2019 | 41.98 | -65.67% | $87.32 | $2.08 |
| 2018 | 122.29 | N/A | $63.59 | $0.52 |
| 2017 | N/A | N/A | $94.71 | -$1.53 |
| 2016 | 182.31 | -93.28% | $100.27 | $0.55 |
| 2015 | 2,711.25 | N/A | $108.45 | $0.04 |
| 2014 | N/A | N/A | $73.11 | -$0.29 |
| 2013 | N/A | N/A | $50.63 | -$0.56 |
| 2012 | N/A | N/A | $16.61 | -$0.34 |
| 2011 | N/A | N/A | $15.01 | -$1.49 |
| 2010 | N/A | N/A | $16.56 | -$0.26 |
Incyte PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 208.79 | -51.63% | $60.55 | $0.29 |
| Dec 2024 | 431.69 | 11.03% | $69.07 | $0.16 |
| Sep 2024 | 388.82 | 143.73% | $66.1 | $0.17 |
| Jun 2024 | 159.53 | 832.38% | $60.62 | $0.38 |
| Mar 2024 | 17.11 | -27.25% | $56.97 | $3.33 |
| Dec 2023 | 23.52 | -23.06% | $62.79 | $2.67 |
| Sep 2023 | 30.57 | -19.47% | $57.77 | $1.89 |
| Jun 2023 | 37.96 | -23.31% | $62.25 | $1.64 |
| Mar 2023 | 49.5 | -5.71% | $72.27 | $1.46 |
| Dec 2022 | 52.5 | 211.94% | $80.32 | $1.53 |
| Sep 2022 | 16.83 | -5.4% | $66.64 | $3.96 |
| Jun 2022 | 17.79 | -5.47% | $75.97 | $4.27 |
| Mar 2022 | 18.82 | 10.25% | $79.42 | $4.22 |
| Dec 2021 | 17.07 | -39.68% | $73.4 | $4.3 |
| Sep 2021 | 28.3 | -48.2% | $68.78 | $2.43 |
INCY Price vs fair value
INCY average PE ratio chart
Currently, INCY's PE ratio is greater than its 3, 5 and 10-year historical averages.
INCY PE vs peers
INCY's PE ratio is higher than its peer stocks LLY and NVS. Incyte's current PE ratio of 236.03 is comparable to the average of its peer group, which is 31.86.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PFE Pfizer Inc | 18.26 | $144.29B |
| NVS Novartis AG | 18.93 | $238.84B |
| AMGN Amgen Inc | 26.99 | $160.37B |
| LLY ELI LILLY & Co | 63.26 | $739.87B |
| INCY Incyte Corp | 236.03 | $13.25B |
| LGND Ligand Pharmaceuticals Inc | N/A | $2.21B |
| ARDX Ardelyx Inc | N/A | $1.02B |
| GERN Geron Corp | N/A | $910.79M |
Frequently asked questions
What is Incyte's PE ratio?
INCY stock has a price to earnings ratio of 236.03 as of Jul 3, 2025.
What is the 3-year average PE ratio for Incyte (INCY)?
As an average over the last 3 years, INCY stock has a PE ratio of 128.8.
What is the 5-year average PE ratio for Incyte (INCY)?
As an average over the last 5 years, INCY stock has a PE ratio of 93.56.
What is the highest PE ratio for INCY?
Over the last ten years, the quarterly PE ratio reached a historic high of 2,711.25 in the Dec 2015 quarter.
How does the current PE ratio for INCY compare to its historical average?
INCY's price to earnings ratio is currently 18% above its 10-year historical average.
Why is Incyte's PE ratio so high?
INCY's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
How is INCY's PE ratio calculated (Incyte PE ratio formula)?
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 3, 2025), Incyte's stock price is $68.45. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.29. Therefore, Incyte's P/E ratio for today is 236.03. PE RATIO(236.03) = STOCK PRICE($68.45) / TTM EPS($0.29)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.